113 related articles for article (PubMed ID: 35932496)
1. Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients.
Castrogiovanni P; Barbagallo I; Imbesi R; Musumeci G; Sanfilippo C; Broggi G; Caltabiano R; Tibullo D; Giallongo C; Forte S; Li Volti G; Di Rosa M
Pathol Res Pract; 2022 Sep; 237():154038. PubMed ID: 35932496
[TBL] [Abstract][Full Text] [Related]
2. Brain
Castrogiovanni P; Sanfilippo C; Imbesi R; Maugeri G; Lo Furno D; Tibullo D; Castorina A; Musumeci G; Di Rosa M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924468
[TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of a Novel Monoclonal Antibody Against Chitinase-like Protein CHID1 Applicable for Immunohistochemistry on Formalin Fixed Paraffin-Embedded Sections.
Samoilova DV; Kovaleva OV; Shelekhova KV; Petrenko AA; Kurochkin SN; Fedotov RV; Gratchev A
Monoclon Antib Immunodiagn Immunother; 2019 Feb; 38(1):12-17. PubMed ID: 30657411
[TBL] [Abstract][Full Text] [Related]
4. Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients.
Di Rosa M; Di Cataldo A; Broggi G; Caltabiano R; Tibullo D; Castrogiovanni P; Imbesi R; Lanteri R; Salomone F; Raciti G; Li Volti G
Sci Rep; 2023 Jan; 13(1):1490. PubMed ID: 36707698
[TBL] [Abstract][Full Text] [Related]
5. CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer.
Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Tabiev RM; Mochalnikova VV; Gratchev A
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466316
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study.
Ibrahiem AT; Fawzy MS; Abu AlSel BT; Toraih EA
J Clin Lab Anal; 2021 Mar; 35(3):e23679. PubMed ID: 33296098
[TBL] [Abstract][Full Text] [Related]
7. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
8. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
Yukimoto R; Nishida N; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Satoh T; Hirofumi Y; Mizushima T; Doki Y; Eguchi H
Cancer Sci; 2021 Jul; 112(7):2884-2894. PubMed ID: 33934428
[TBL] [Abstract][Full Text] [Related]
9. Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer.
Song K; Lu H; Jin L; Wang K; Guo W; Zheng H; Li K; He C; You T; Fu Y; Yang J; Zhao W; Guo Z
FEBS J; 2020 Dec; 287(23):5236-5248. PubMed ID: 32216031
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. BRAF
Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
[TBL] [Abstract][Full Text] [Related]
13. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis.
Liu D
Cell Oncol (Dordr); 2019 Apr; 42(2):197-209. PubMed ID: 30645729
[TBL] [Abstract][Full Text] [Related]
14. SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.
Lundberg IV; Löfgren Burström A; Edin S; Eklöf V; Öberg Å; Stenling R; Palmqvist R; Wikberg ML
PLoS One; 2014; 9(7):e101957. PubMed ID: 25010701
[TBL] [Abstract][Full Text] [Related]
15. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract][Full Text] [Related]
16. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
18. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.
Popēna I; Ābols A; Saulīte L; Pleiko K; Zandberga E; Jēkabsons K; Endzeliņš E; Llorente A; Linē A; Riekstiņa U
Cell Commun Signal; 2018 Apr; 16(1):17. PubMed ID: 29690889
[TBL] [Abstract][Full Text] [Related]
19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]